Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Hamilton Lane $162.4 Million Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $162.4 million SEC-registered follow-on offering…
YUM! Brands $800 Million Senior Notes Offering
Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by YUM! Brands, Inc. of $800 million…
YUM! Brands $800 Million Senior Notes Offering
Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by YUM! Brands, Inc. of $800 million…
Davis Polk Advised a Joint Venture between Slate Property Group and Vanke US on the $157.526 Million Sale of 45 Rivington Street, New York, NY
Davis Polk advised a joint venture between Slate Property Group and Vanke US on the $157.526 million sale of its fee…
$157.526 million sale of 45 Rivington Street, New York, NY
We advised a joint venture between Slate Property Group and Vanke US on the sale
YUM! Brands $800 Million Senior Notes Offering
Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by YUM! Brands, Inc. of $800 million…
ING Groep N.V. $1.5 Billion Perpetual Additional Tier 1 Contingent Convertible Capital Securities
Davis Polk advised the joint bookrunners in connection with an SEC-registered offering of $1.5 billion aggregate principal…
Turning Point Therapeutics, Inc. $202.5 Million Follow-On Offering
Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point…
iRhythm Technologies, Inc. $115 Million Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC…
Turning Point Therapeutics, Inc. $202.5 Million Follow-On Offering
Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point…